Excellent survival and good outcomes at 15 years using the Press Fit Condylar Sigma total knee replacement by Oliver, William M. et al.
Accepted Manuscript
Excellent Survival And Good Outcomes At 15 Years Using The Press Fit Condylar
Sigma Total Knee Replacement
William M. Oliver, LLB (Hons), MRCS (Orthopaedic Registrar), Calum HC. Arthur,
FRCS (Tr & Orth) (Orthopaedic Consultant), Alexander M. Wood, MSc, FRCS (Tr
& Orth) (Orthopaedic Consultant), Robert AE. Clayton, BSc (Hons), FRCS (Tr &
Orth) (Orthopaedic Consultant), Ivan J. Brenkel, FRCS (Tr & Orth) (Orthopaedic
Consultant), Philip Walmsley, MD, FRCS (Tr & Orth) (Orthopaedic Consultant)
PII: S0883-5403(18)30306-1
DOI: 10.1016/j.arth.2018.03.048
Reference: YARTH 56540
To appear in: The Journal of Arthroplasty
Received Date: 5 January 2018
Revised Date: 5 March 2018
Accepted Date: 19 March 2018
Please cite this article as: Oliver WM, Arthur CH, Wood AM, Clayton RA, Brenkel IJ, Walmsley P,
Excellent Survival And Good Outcomes At 15 Years Using The Press Fit Condylar Sigma Total Knee
Replacement, The Journal of Arthroplasty (2018), doi: 10.1016/j.arth.2018.03.048.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
EXCELLENT SURVIVAL AND GOOD OUTCOMES AT 15 YEARS USING THE 
PRESS FIT CONDYLAR SIGMA TOTAL KNEE REPLACEMENT 
 
William M Oliver LLB (Hons), MRCS (Orthopaedic Registrar)1 
Calum HC Arthur FRCS (Tr & Orth) (Orthopaedic Consultant)2 
Alexander M Wood MSc, FRCS (Tr & Orth) (Orthopaedic Consultant)3 
Robert AE Clayton BSc (Hons), FRCS (Tr & Orth) (Orthopaedic Consultant)1 
Ivan J Brenkel FRCS (Tr & Orth) (Orthopaedic Consultant)1 
Philip Walmsley MD, FRCS (Tr & Orth) (Orthopaedic Consultant)1 
 
1Victoria Hospital, Hayfield Road, Kirkcaldy, Fife, KY2 5AH, UK 
2Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh, Midlothian, EH16 4SA, UK 
3Leeds General Infirmary, Great George Street, Leeds, West Yorkshire, LS1 3EX, UK 
 
 
Corresponding Author 
 
Mr William M Oliver 
Orthopaedic Registrar 
Royal Infirmary of Edinburgh 
51 Little France Crescent 
Edinburgh 
Midlothian 
EH16 4SA 
UK 
Tel: +44 7786 438 530 
Email: william.m.oliver@doctors.org.uk 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
1
EXCELLENT SURVIVAL AND GOOD OUTCOMES AT 15 YEARS USING 1 
THE PRESS FIT CONDYLAR SIGMA TOTAL KNEE REPLACEMENT 2 
 3 
Abstract 4 
 5 
Background:  We report 15-year survival, clinical and radiographic follow-up data for the 6 
Press Fit Condylar Sigma total knee replacement (PFC Sigma TKR). 7 
 8 
Methods:  Between October 1998 and October 1999, 235 consecutive TKRs were performed 9 
in 203 patients.  Patients were reviewed at a specialist nurse-led clinic prior to surgery, and at 10 
five, eight-to-ten and 15 years postoperatively.  Clinical outcomes, including Knee Society 11 
Score (KSS), were recorded prospectively at each clinic visit, and radiographs were obtained. 12 
 13 
Results:  Of our initial cohort, 99 patients (118 knees) were alive at 15 years, and 31 patients 14 
(34 knees) were lost to follow-up.  13 knees (5.5%) were revised; five (2.1%) for infection, 15 
seven (3%) for instability and one (0.4%) for aseptic loosening.  Cumulative survival with the 16 
end-point of revision for any reason was 92.3% at 15 years, and with revision for aseptic 17 
failure as the end-point was 94.4%.  The mean KSS knee score was 77.4 (33 to 99) at 15 18 
years, compared with 31.7 (2 to 62) preoperatively.  Of 71 surviving knees for which X-rays 19 
were available, 12 (16.9%) had radiolucent lines and one (1.4%) demonstrated clear 20 
radiographic evidence of loosening. 21 
 22 
Conclusion:  The PFC Sigma TKR represents a durable, effective option for patients 23 
undergoing knee arthroplasty, with excellent survival and good clinical and radiographic 24 
outcomes at 15 years. 25 
 26 
 27 
Keywords 28 
 29 
Total knee arthroplasty; implant survival; patient-reported outcome measures   30 
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Introduction 31 
 32 
The Press Fit Condylar Total Knee Replacement (Johnson & Johnson Professional, 33 
Raynham, Massachusetts) has been commercially available since 1984.  Despite a reported 34 
ten-year survivorship between 93%[1, 2] and 95%,[3] in some series a deterioration in implant 35 
survival was observed beyond ten years postoperatively.[4-9] 36 
 37 
The Sigma design succeeded the original PFC TKR, arriving on the UK market in 1997.  38 
Novel features included an increased radius of medio-lateral femoral condylar curvature, with 39 
a corresponding deepening of the polyethylene insert, and modification of the femoral 40 
trochlea creating a deeper groove and a more pronounced lateral epicondylar ridge.[10] 41 
 42 
We have previously reported results of this device up to ten years post-implantation, 43 
demonstrating all-cause survivorship of 95.9% and survivorship for aseptic loosening of 44 
98.7%.[11]  Studies extending beyond ten years are scarce,[12] but suggest the decline in 45 
implant survival observed in the original design does not extend to the current version.  By 46 
following our cohort out to 15 years postoperatively, we will evaluate whether the PFC Sigma 47 
TKR continues to represent a durable, effective option for patients undergoing total knee 48 
arthroplasty.  49 
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Patients and Methods 50 
 51 
This device was introduced in our unit in October 1998.  Between October 1998 and October 52 
1999, all patients undergoing unilateral primary TKR were included in this study.  This 53 
unselected, consecutive group formed our study cohort, and is the same cohort used in the 54 
report of our ten-year results.[11]  No other prostheses were used in the department during 55 
the study period, with unicompartmental, simultaneous bilateral and revision procedures 56 
excluded from the analysis.  A summary of baseline demographic details and indication for 57 
index TKR is shown in Table I. 58 
 59 
In our department, we employ a group of four specialist nurses who review all patients 60 
undergoing TKR, and the composition of this group remained constant throughout the study 61 
period.  They were not part of the study team, and reviewed all patients undergoing TKR 62 
during the study period (not just the study cohort).  Patients were reviewed by our specialist 63 
nurses at a pre-admission clinic prior to surgery, and at five years, eight-to-ten years and 15 64 
years postoperatively.  Data including age, gender, weight, height, medical co-morbidities and 65 
clinical outcome scores were recorded prospectively using a standardised data collection 66 
form, from which data was then entered into the departmental arthroplasty database.  67 
Radiographs were also obtained at these appointments. 68 
 69 
The operations were performed by six different consultant surgeons, or by trainees under 70 
direct supervision.  The surgical technique is as described in our previous results.[11]  71 
Specifically, the decision to resurface the patella was left to the discretion of the consultant 72 
surgeon, and drains were not used routinely.  All patients underwent a standard regime of 73 
postoperative care, including mechanical and chemical thromboprophylaxis with 74 
thromboembolic deterrent stockings and subcutaneous low molecular weight heparin.  A 75 
standardised transfusion protocol was in place during the study, with a trigger haemoglobin 76 
value of 8g/dL. 77 
 78 
Using data entered into the departmental arthroplasty database, pre-programmed algorithms 79 
were used to calculate the Knee Society Score (KSS)[13] and Oxford Knee Score (OKS)[14] 80 
for all study patients.  The OKS was categorised as ‘Excellent’, ‘Good’, ‘Fair’ or ‘Poor’, using 81 
published thresholds.[15] 82 
 83 
Weight-bearing short-leg anteroposterior and lateral X-rays were obtained for all patients who 84 
attended their 15-year follow-up appointment.  Coronal plane alignment (femorotibial valgus 85 
angle) was measured, and femoral and tibial components were assessed for the presence of 86 
surrounding radiolucent lines or osteolytic defects.[16]  Images were reviewed by three 87 
surgeons using Carestream Picture Archiving Communication Software (PACS), all of whom 88 
were blinded to the that particular patient’s outcome at the time of X-ray assessment. 89 
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 90 
A life table was constructed and cumulative survival rates were calculated.  End-points were 91 
re-operation for any reason, and component revision for aseptic loosening or mechanical 92 
failure.  A ‘worst case’ survival analysis was also performed, whereby all knees lost to follow-93 
up were treated as having failed immediately after their last follow-up appointment.  94 
Confidence intervals for survival rates were calculated using the Rothman method,[17, 18] 95 
which has been validated for this purpose.[19, 20]  Where appropriate, a paired t-test was 96 
used to assess statistical significance of the relationship between two continuous variables. 97 
98 
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Results 99 
 100 
From an original cohort of 203 patients (235 knees), at 15 years postoperatively, 104 patients 101 
(117 knees) had died, leaving 99 patients (118 knees) alive and theoretically available for 102 
follow-up.  This equates to a death rate of 3.4% per year.  Of the surviving cohort, 60 patients 103 
(76 knees) attended clinic, seven patients (seven knees) were contacted by telephone, and 104 
one patient (one knee) responded by letter. Responses by telephone and letter provided data 105 
for the KSS pain component of the knee score and KSS function score, as well as OKS; 106 
however a complete KSS knee score (which includes clinical assessment of alignment, range 107 
of motion and stability) was unavailable for these patients.  31 patients (34 knees) did not 108 
attend clinic, and were therefore lost to follow-up.  A summary of 15-year follow-up is shown 109 
in Figure 1.   110 
 111 
KSS knee scores were available for 76 knees (64.4%) who attended their final clinic 112 
appointment, while pain component scores and function scores were available for a further 113 
seven knees who were contacted by telephone (83 knees, 70.3%). 114 
 115 
The mean KSS knee score at 15 years postoperatively was 77.4 (33 to 99), showing little 116 
deterioration from the five-year (84.3, 35 to 99) and ten-year (78.8, 10 to 99) scores.  117 
Similarly, the mean pain component of the knee score was 39.5 (0 to 50) at 15 years, only 118 
slightly reduced from the five-year (44.3, 0 to 50) and ten-year (41.3, 10 to 50) scores.  119 
Clinically, this corresponds to mild knee pain when climbing stairs.  32 of 83 patients (38.6%) 120 
reported no pain. 121 
 122 
In contrast to the KSS knee and pain component scores, the mean function score at 15 years 123 
was 56.4 (5 to 100), a marked decrease from the five-year (80.5, 30 to 100) and ten-year 124 
(68.9, 20 to 100) function scores.  Postoperative trends in the KSS are shown in Figure 3. 125 
 126 
Oxford Knee Scores were available for 77 knees (65.3%) at 15 years.  The mean OKS was 127 
29.0 (3 to 48), representing a ‘Fair’ outcome.  Analysis of previous results from this cohort 128 
(Table IV) indicates a general decline in OKS from five to 15 years postoperatively, with a 129 
marked decrease in the proportion of knees classed as ‘Excellent’ and an associated 130 
increase in those classed as ‘Poor’; the proportion of knees in the ‘Good’ and ‘Fair’ category 131 
is relatively constant. Distribution of postoperative OKS is shown in Figure 4. 132 
 133 
Radiographic data were available for 71 knees (60.2%) at final review.  Of these, 12 knees 134 
(16.9%) had radiolucent lines.  A summary of the distribution of radiolucent lines on AP and 135 
lateral radiographs is shown in Table V. 136 
 137 
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Clinically, five patients with radiolucent lines had occasional mild pain (KSS pain component 138 
score = 45), and the remainder reported no pain (KSS pain component score = 50). 139 
 140 
One knee (1.4%) had osteolysis on the AP radiograph, which demonstrated a 3mm erosion in 141 
zone 1 and 6mm erosion in zone 4 beneath the tibial component. 142 
 143 
Of 71 knees, 62 were in valgus, five were in neutral (femorotibial angle = zero degrees) and 144 
four were in varus alignment.  The mean coronal plane alignment was 4.1 degrees valgus 145 
(range 9 degrees valgus to 5 degrees varus).  The alignment of 24 knees (33.8%) was found 146 
to be outwith the recommended range of 7±3 degrees valgus.[28]  Seven of these 24 knees 147 
(29.2%) demonstrated radiolucent lines.  A summary of radiolucent lines by coronal plane 148 
alignment is shown in Table VI. 149 
 150 
Overall, 11 patients (13 knees, 5.5%) required a revision procedure.  Five knees (2.1%) 151 
underwent a two-stage revision for deep prosthetic infection, all within three years of their 152 
index procedure.  Seven knees (3%) underwent change of polyethylene insert for coronal 153 
plane instability secondary to polyethylene wear.  In all of these cases the femoral and tibial 154 
components were found to be well-fixed at the time of surgery.  Two patients, both of whom 155 
underwent surgery for deep infection in the third postoperative year, required subsequent 156 
revision surgery for reasons other than infection.  One patient developed symptomatic aseptic 157 
loosening in the tenth year following index TKR, requiring a single-stage revision to a hinged 158 
prosthesis; the other patient, who had rheumatoid arthritis, developed instability with synovitis 159 
and underwent change of polyethylene insert in the 11th year following index TKR.  A 160 
summary of patients whom underwent revision surgery is shown in Table II. 161 
 162 
At 15 years postoperatively, survival rate with revision for any reason as the end-point was 163 
92.3% (95% CI 84.9 to 96.2).  15-year survival rate with revision for aseptic failure as the end-164 
point was 94.4% (95% CI 87.6 to 97.6).  The ‘worst-case’ survival rate, in which all knees lost 165 
to follow-up are presumed to have failed immediately following their last follow-up 166 
appointment, was 73.2% (95% CI 63.2 to 81.3).  The life table and Kaplan-Meier survival 167 
curve are shown in Table III and Figure 2.  168 
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Discussion 169 
 170 
The PFC Sigma TKR represents a durable, effective option for patients undergoing knee 171 
arthroplasty, with excellent survival and good clinical and radiographic outcomes at 15 years.  172 
Since its introduction it has become a popular prosthesis in the UK, accounting for 34.4% of 173 
primary TKRs in 2016.[21]  The UK National Joint Registry determines the cumulative risk of 174 
revision to be 2.65% at ten years.[21]  Previous data from this Unit,[11, 22, 23] and 175 
others,[24-26] have shown excellent prosthesis survival, clinical and radiographic outcomes 176 
for the fixed-bearing prosthesis up to ten years postoperatively.  Our analysis has shown 177 
continuing longevity of the PFC Sigma TKR up to 15 years postoperatively, which is the 178 
longest reported follow-up for this prosthesis. 179 
 180 
In our cohort, 8.1% of patellae were resurfaced at index TKR, and no patient required revision 181 
for patellar resurfacing up to 15 years postoperatively.  This is consistent with all other long-182 
term reports of the PFC Sigma TKR, and contrasts with series relating to its predecessor in 183 
which revisions for patellofemoral pain and instability were described.[1, 3, 6] 184 
 185 
The mean 15-year KSS knee score showed very minimal deterioration from 5-year and 10-186 
year scores, and the same was apparent in the pain component score.  In the only other 187 
series assessing KSS beyond ten years postoperatively, Patil et al. report a mean KSS knee 188 
score of 84.4 for 39 knees at a mean 11.8 years,[12] and thus the mean 15-year score for our 189 
cohort (77.4) compares favourably. 190 
 191 
In contrast, we observed a reduction in KSS function score from 80.5 at five years, and 68.9 192 
at ten years, to 56.4 at 15 years.  The causes for this functional decline do not appear to be 193 
related to either pain within or the objective performance of the prosthesis.  As has been 194 
postulated, this decline may be an indicator of general activity limitation due to advancing age 195 
or co-morbidity.[27]  Regardless, previous studies have estimated the minimal clinically-196 
important difference in KSS function score to be 34.5 points,[28] and so this 24.1-point 197 
deterioration may not be of relevance to patients. 198 
 199 
The mean 15-year OKS was 29, classed as ‘Fair’, indicating a general decline in OKS from 200 
five to 15 years postoperatively; this corresponds with the deterioration in KSS function score, 201 
and again may simply reflect age-related restrictions in functional ability and activities of daily 202 
living.  The expected reduction in postoperative OKS over the first 10 years following TKR 203 
has been estimated at 4.2 points.[29]   204 
 205 
Radiographs of 71 knees attending 15-year follow-up demonstrated non-progressive 206 
radiolucent lines in 16.9%, and radiological loosening in 1.4% (one knee).  Previous results 207 
from this cohort demonstrated radiolucent lines in 43.1%,[11] which suggests a 208 
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disproportionate number of those with radiolucent lines at ten years either died or were lost to 209 
follow-up by 15 years.  Radiolucent lines did not correlate with pain (mean KSS pain 210 
component score 47.9). 211 
 212 
The mean coronal plane alignment was 4.1 degrees valgus, which is within the recommended 213 
range of 7±3 degrees valgus.[30]  Interestingly, knees that were ‘malaligned’ appeared more 214 
likely to demonstrate radiolucent lines on 15-year X-rays (29.2%) than those that were not 215 
(10.6%).  Due to the small sample size, however, this difference was not statistically 216 
significant (p=0.55). 217 
 218 
We identified 13 revision procedures (5.5%) prior to 15 years post-implantation, which 219 
amounts to five additional revisions between ten and 15 years postoperatively.  One further 220 
TKR from the cohort of 235 knees (0.4%) required revision for aseptic loosening at 15 years 221 
postoperatively.  This does not appear to represent an excessive deterioration in implant 222 
survival, as was observed for the original design.  223 
 224 
Two patients required a second revision procedure, both after having undergone two-stage 225 
revision for deep prosthetic infection in the third year following index TKR.  Both patients had 226 
recognised risk factors for infection; both were male[31-33] cigarette-smokers, one had 227 
rheumatoid arthritis[31, 34, 35] and the other was morbidly obese[33, 36] (BMI 42kg/m2).  228 
These baseline risk factors, in combination with early revision surgery itself,[37] increase the 229 
risk of subsequent revision surgery; however it is reassuring that neither subsequent revision 230 
was due to infection (indications = aseptic loosening and instability) and that there was a 231 
relatively long time interval between the first and second revision procedures (86 and 99 232 
months, respectively).  This suggests their initial revisions for infection had been effective. 233 
 234 
Using an end-point of revision for any reason, implant survival in our cohort was 92.3% at 15 235 
years, and using revision for aseptic loosening as an end-point survival was 94.4%.  Prior to 236 
our study, the longest follow-up for this prosthesis had been a single-surgeon series of 79 237 
TKRs, in which Patil et al. reported 14-year survival of 97% using revision for any reason and 238 
100% using loosening as end-points.[12]  Accounting for length of follow-up our results are 239 
comparable, suggesting ongoing durability for this prosthesis and supporting its continued 240 
use. 241 
 242 
Previous studies assessing long-term survivorship of the original PFC TKR have quoted 243 
survival rates from 84.6%[8] to 92.6%[5] at 15 years; the latter results reported in a single-244 
surgeon series of 139 TKRs in Boston, Massachusetts, where the prosthesis was designed. 245 
 246 
As well as comparing our results with other published series of the same design, it is 247 
important to consider long-term reports of different designs of condylar knee prosthesis, as 248 
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the implant design may confer an advantage in terms of longevity.  Schwartz et al. reported 249 
10-year survivorship for 179 third-generation cruciate-retaining TKRs of 97.7% and 100%, 250 
with end-points of revision for any reason and revision for loosening, respectively.[38]   251 
Another report of a mean 11.2 year follow-up for 113 hybrid TKRs demonstrated a survival 252 
rate of 93.8% with revision for any reason as the end-point, and 96.5% for revision for 253 
loosening as the end-point.[39]  A comparative analysis of the Genesis I and II designs (Smith 254 
& Nephew, Memphis, Tennessee) described an overall survival of 92.4% at 15 years, which 255 
compares well with our results.[40]  There are few published TKR series extending into the 256 
third decade, although one series of the Anatomic Graduated Component TKR (Biomet, 257 
Warsaw, Indiana) at 25-30 years post-implantation reported overall survival of 94.2% at 25 258 
years and 92.4% at 30 years.[41]  At these time-points patients were at greater statistical risk 259 
of dying than of undergoing revision surgery; however, of revisions carried out by this point 260 
the commonest indication was aseptic loosening, with instability the second most common. 261 
 262 
The principal limitation of our study is the high rate of loss to follow-up.  34 of 235 knees 263 
(14.5%) were lost to follow-up; this is reflected in our ‘worst case’ survival rate of 73.8% at 15 264 
years.  Several other studies assessing long-term outcomes of the original PFC and PFC 265 
Sigma TKR have more favourable rates of loss to follow-up,[5-7, 12] and therefore better 266 
‘worst case’ survival, although all began with cohorts of less than 160 TKRs.  Larger cohorts, 267 
such as ours, represent a particular challenge when collating 15-year follow-up data. 268 
 269 
Moreover, only 60 of 99 surviving patients (74 of 118 surviving knees, 62.7%) were reviewed 270 
in the clinic, with a further 8 patients (8 knees) reviewed remotely (by telephone or letter).  271 
This not only limits the type of outcome data that can be obtained (in particular the KSS knee 272 
score, which requires clinical examination), but potentially introduces bias.  Home visits were 273 
not considered appropriate or practical, due to patient co-morbidity or institutionalisation, or 274 
patients having moved away from the region. 275 
 276 
Radiographic follow-up, available for 71 of 76 knees attending clinic, consisted of short-leg 277 
weight-bearing radiographs.  Although these X-rays are considered suitable for assessing 278 
TKR alignment in general clinical practice, full-length (hip-knee-ankle) radiographs are 279 
generally preferable in a research setting.[42] 280 
 281 
Our cohort of patients was operated upon by a range of surgeons, including consultants 282 
without a subspecialty interest in knee arthroplasty and supervised trainees, in a district 283 
general hospital.  These results, therefore, are highly applicable to general orthopaedic 284 
practice.  Our results update previous studies from our unit,[11, 22, 23] and continue to 285 
confirm excellent survivorship and good clinical and radiographic outcomes for the PFC 286 
Sigma TKR at 15 years postoperatively.  287 
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Table I: Baseline patient details and indication for PFC Sigma TKR 
Age (years) 66.5 (28 to 91) 
Gender (n, %) Male:  100, 49.3% 
Female:  103, 50.7% 
Weight (kg) 81.4 (43 to 133) 
Height (m) 1.63 (1.39 to 1.88) 
Body mass index (kg/m2) 30.5 (17 to 49) 
Indication for TKR (n, %) Osteoarthritis:  209, 88.9% 
Rheumatoid arthritis:  20, 8.5% 
Post-traumatic arthritis:  6, 2.6% 
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Table II: Revision procedures, listed according to indication and time of revision 
Indication 
Time of 
revision 
(months) 
Age 
(years) Gender Smoker 
BMI 
(kg/m2) 
Primary 
diagnosis Procedure 
Infection 
(mixed) 5 67 Male Yes 25.6 OA 
Two-stage 
revision 
Infection 
(Staph. aureus) 9 70 Male Ex 35.2 OA 
Two-stage 
revision 
Infection 
(mixed) 13 77 Male Ex 27.2 OA 
Two-stage 
revision 
Infection 
(mixed) 26 53 Male Yes 26.9 RA 
Two-stage 
revision 
Infection 
(Staph. aureus) 27 68 Male Yes 42.0 OA 
Two-stage 
revision 
Instability 59 62 Male No 25.1 OA Poly exchange 
Aseptic loosening 113 68 Male Yes 42.0 OA Hinged TKR 
Instability 119 49 Female Ex 32.3 OA Poly exchange 
Instability 123 62 Male No 26.4 OA Poly exchange 
Instability, 
synovitis 125 53 Male Yes 26.9 RA Poly exchange 
Instability 126 64 Female Ex 34.5 OA Poly exchange 
Instability 128 50 Female No 23.4 OA Poly exchange 
Instability 136 74 Male Ex 28.7 OA Poly exchange 
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Table III: Life table for survival of the PFC Sigma TKR 
Year Number at start Death LTFU Failure Number 
at risk 
Annual failure 
rate (%) 
Annual survival 
rate (%) 
Cumulative 
survival (%) 
Cumulative 'worst 
case' survival (%) 
Survival with revision 
for aseptic failure (%) 
1 235 6 3 2 230.5 0.9 99.1 99.1 (96.9 to 99.8) 97.8 (95.0 to 99.0) 100.0 (98.4 to 100) 
2 224 6 0 1 221 0.5 99.5 98.7 (96.2 to 99.6) 97.4 (94.4 to 98.3) 100.0 (98.4 to 100) 
3 217 9 2 2 211.5 0.9 99.1 97.8 (94.7 to 99.1) 95.5 (91.8 to 97.6) 100.0 (98.2 to 100) 
4 204 10 0 0 199 0.0 100.0 97.8 (94.6 to 99.1) 95.5 (91.7 to 97.6) 100.0 (98.1 to 100) 
5 194 10 1 1 188.5 0.5 99.5 97.2 (93.8 to 98.8) 94.5 (90.3 to 96.9) 99.5 (97.1 to 100) 
6 182 5 2 0 178.5 0.0 100.0 97.2 (93.7 to 98.8) 93.5 (88.9 to 96.3) 99.5 (97.0 to 100) 
7 175 4 3 0 171.5 0.0 100.0 97.2 (93.6 to 98.8) 91.8 (86.7 to 95.0) 99.5 (96.8 to 100) 
8 168 5 3 0 164 0.0 100.0 97.2 (93.4 to 98.9) 90.2 (84.7 to 96.6) 99.5 (96.7 to 100) 
9 160 5 4 0 155.5 0.0 100.0 97.2 (93.3 to 98.9) 87.8 (81.7 to 92.0) 99.5 (96.7 to 100) 
10 151 4 0 2 149 1.3 98.7 95.9 (91.4 to 98.1) 86.7 (80.3 to 91.3) 98.1 (94.4 to 99.4) 
11 145 4 16 4 135 3.0 97.0 93.1 (87.5 to 96.3) 73.8 (65.8 to 80.5) 95.2 (90.2 to 97.7) 
12 121 6 0 1 118 0.8 99.2 92.3 (86.0 to 95.9) 73.2 (64.6 to 80.4) 94.4 (88.7 to 97.3) 
13 114 9 0 0 109.5 0.0 100.0 92.3 (85.7 to 96.0) 73.2 (64.2 to 80.6) 94.4 (88.4 to 97.4) 
14 105 9 0 0 100.5 0.0 100.0 92.3 (85.4 to 96.1) 73.2 (63.8 to 80.9) 94.4 (88.1 to 97.5) 
15 96 12 0 0 90 0.0 100.0 92.3 (84.9 to 96.2) 73.2 (63.2 to 81.3) 94.4 (87.6 to 97.6) 
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Table IV: Postoperative Oxford Knee Score classification, following PFC Sigma TKR 
OKS classification (n, %) 5 years (N=216) 10 years (N=131) 15 years (N=77) 
Excellent (42 to 48) 66, 30.6% 34, 26.3% 9, 11.7% 
Good (34 to 41) 59, 27.2% 46, 34.1% 24, 31.2% 
Fair (27 to 33) 49, 22.7% 25, 19.3% 14, 18.2% 
Poor (<27) 42, 19.3% 26, 20.1% 30, 39.0% 
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Table V: Distribution of radiolucent lines on AP and lateral radiographs 
 1 zone 2 zones 3 zones 4 zones 
AP only 2 3 0 0 
Lateral only 3 0 1 0 
AP and lateral 0 1 1 1 
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Table VI: Distribution of radiolucent lines by coronal plane alignment 
Radiolucent lines (n, %) 7±3 degrees valgus (N=47) <4 degrees valgus (N=24) 
AP only 1, 2.1% 4, 16.7% 
Lateral only 2, 4.3% 2, 8.3% 
AP & lateral 2, 4.3% 1, 4.2% 
No radiolucent lines 42, 89.4% 17, 70.8% 
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Figure 1: 15-year follow-up of PFC Sigma TKR cohort 
 
 
Figure 2: Cumulative 15-year survival rates for the PFC Sigma TKR 
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Figure 3: Postoperative Knee Society Score following PFC Sigma TKR 
 
 
 
Figure 4: Postoperative Oxford Knee Score classification following PFC Sigma TKR 
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